← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

Director James Arthur Bristol sold $1.3M of Deciphera Pharmaceuticals, Inc.

Sold$1,294,634
$54.99Price
23,541Shares
−100%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Thu, Jul 9. Filed Mon, Jul 13, 12:11 PM ET, during the session. Not investment advice.